Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association Between Antecedent Statin Use and Decreased Mortality in Hospitalized Patients with COVID-19
Aakriti Gupta, Mahesh V. Madhavan, Timothy J. Poterucha, et al.
Research Square (Research Square) (2020)
Open Access | Times Cited: 23

Showing 23 citing articles:

Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies
Behnood Bikdeli, Azita H. Talasaz, Farid Rashidi, et al.
Thrombosis Research (2020) Vol. 196, pp. 382-394
Open Access | Times Cited: 84
Viral myocarditis: 1917–2020: From the Influenza A to the COVID-19 pandemics
Shereif H. Rezkalla, Robert A. Kloner
Trends in Cardiovascular Medicine (2020) Vol. 31, Iss. 3, pp. 163-169
Open Access | Times Cited: 61
Statin use and clinical outcomes in patients with COVID-19: An updated systematic review and meta-analysis
Rimesh Pal, Mainak Banerjee, Urmila Yadav, et al.
Postgraduate Medical Journal (2021) Vol. 98, Iss. 1159, pp. 354-359
Open Access | Times Cited: 53
Improved COVID-19 Outcomes following Statin Therapy: An Updated Systematic Review and Meta-analysis
Amir Vahedian‐Azimi, Seyede Momeneh Mohammadi, Maciej Banach, et al.
BioMed Research International (2021) Vol. 2021, pp. 1-20
Open Access | Times Cited: 53
Statins and clinical outcomes with COVID-19: Meta-analyses of observational studies
André Scheen
Diabetes & Metabolism (2020) Vol. 47, Iss. 6, pp. 101220-101220
Open Access | Times Cited: 49
A meta-analysis on the risk factors adjusted association between cardiovascular disease and COVID-19 severity
Jie Xu, Wenwei Xiao, Xuan Liang, et al.
BMC Public Health (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 49
Statin and outcomes of coronavirus disease 2019 (COVID-19): A systematic review, meta-analysis, and meta-regression
Timotius Ivan Hariyanto, Andree Kurniawan
Nutrition Metabolism and Cardiovascular Diseases (2021) Vol. 31, Iss. 6, pp. 1662-1670
Open Access | Times Cited: 39
The protective association between statins use and adverse outcomes among COVID-19 patients: A systematic review and meta-analysis
Ronald Chow, James Im, Nicholas Chiu, et al.
PLoS ONE (2021) Vol. 16, Iss. 6, pp. e0253576-e0253576
Open Access | Times Cited: 37
HMG-CoA reductase inhibitors and COVID-19 mortality in Stockholm, Sweden: A registry-based cohort study
Rita Bergqvist, Viktor H. Ahlqvist, Michael Lundberg, et al.
PLoS Medicine (2021) Vol. 18, Iss. 10, pp. e1003820-e1003820
Open Access | Times Cited: 34
Computational prediction of the molecular mechanism of statin group of drugs against SARS-CoV-2 pathogenesis
Dipanjan Ghosh, Debabrata Ghosh Dastidar, Kamalesh Roy, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 18
Understanding the Link Between Obesity and Severe COVID-19 Outcomes: Causal Mediation by Systemic Inflammatory Response
Andrea S. Foulkes, Caitlin Selvaggi, Daniel J. Shinnick, et al.
The Journal of Clinical Endocrinology & Metabolism (2021) Vol. 107, Iss. 2, pp. e698-e707
Open Access | Times Cited: 26
Basic mechanisms of SARS-CoV-2 infection. What endocrine systems could be implicated?
Berta Soldevila, Manel Puig‐Domingo, Mónica Marazuela
Reviews in Endocrine and Metabolic Disorders (2021) Vol. 23, Iss. 2, pp. 137-150
Open Access | Times Cited: 22
Pharmacologic therapies of ARDS: From natural herb to nanomedicine
Linlin Meng, Ximing Liao, Yuanyuan Wang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 14
Prior Statin Use and Risk of Mortality and Severe Disease From Coronavirus Disease 2019: A Systematic Review and Meta-analysis
Zachary A. Yetmar, Supavit Chesdachai, Tarek Kashour, et al.
Open Forum Infectious Diseases (2021) Vol. 8, Iss. 7
Open Access | Times Cited: 13
Protecting older patients with cardiovascular diseases from COVID-19 complications using current medications
Mariana Alves, Marília Andreia Fernandes, Gülistan Bahat, et al.
European Geriatric Medicine (2021) Vol. 12, Iss. 4, pp. 725-739
Open Access | Times Cited: 9
Role of Statins in Coronavirus-Related Disease (COVID-19): A Retrospective Cohort Study in Northern Italy
Salvatore Greco, Andrea D’Amuri, Enrico Giorgini, et al.
High Blood Pressure & Cardiovascular Prevention (2021) Vol. 28, Iss. 4, pp. 355-364
Open Access | Times Cited: 7
Comment on: “Prior Treatment with Statins is Associated with Improved Outcomes of Patients with COVID-19: Data from the SEMI-COVID-19 Registry”
Alpo Vuorio, Petri T. Kovanen
Drugs (2021) Vol. 81, Iss. 9, pp. 1125-1127
Open Access | Times Cited: 3
A historical cohort study to investigation of statins safety in COVID-19 hospitalized patients
Saeed Nateghi, Mohammad Mahmoudi Gomari, Hadiseh Hosamirudsari, et al.
Therapies (2021) Vol. 77, Iss. 4, pp. 453-460
Open Access | Times Cited: 3
Pre-Admission Beta-Blocker Therapy and Outcomes of Coronavirus Disease 2019 (COVID-19): A Systematic Review, Meta-Analysis, and Meta-Regression
Andree Kurniawan, Timotius Ivan Hariyanto, Joshua Edward Hananto, et al.
Cardiovascular & Haematological Disorders - Drug Targets (2022) Vol. 22, Iss. 2, pp. 104-117
Closed Access | Times Cited: 2
Evaluation of pheniramine maleate and zofenopril in reducing renal damage induced by unilateral ureter obstruction. An experimental study
Ercan Yuvanç, Devrim Tuğlu, Tunç Ozan, et al.
Archives of Medical Science (2019) Vol. 17, Iss. 3, pp. 812-817
Open Access | Times Cited: 1
CRITICAL CARE COVID-19 MANAGEMENT PROTOCOL: CLINICAL CASE
Maryana Cherkes, Puya Dehgani‐Mobaraki
Proceedings of the Shevchenko Scientific Society Medical Sciences (2020) Vol. 62, Iss. 2
Open Access | Times Cited: 1
Phenotypical and Functional Alteration of γδ T Lymphocytes in COVID-19 Patients: Reversal by Statins
Marta Di Simone, Anna Maria Corsale, Elena Lo Presti, et al.
Cells (2022) Vol. 11, Iss. 21, pp. 3449-3449
Open Access
Lipid-lowering therapy in high cardiovascular risk patients during COVID-19 pandemic: keep focused on the target
Arturo Cesaro, Carmine Riccio, Paolo Calabrò
Monaldi Archives for Chest Disease (2021) Vol. 91, Iss. 2
Open Access
Page 1

Scroll to top